A new case of adult Acute Myeloid Leukemia with t(3;3)(p24;q26) by Yuan, Bo et al.
Case Report Section 
Atlas Genet Cytogenet Oncol Haematol. 2019; 23(7) 204 
Atlas of Genetics and Cytogenetics 
in Oncology and Haematology 
INIST-CNRS OPEN ACCESS JOURNAL 
A new case of adult Acute Myeloid Leukemia 
with t(3;3)(p24;q26) 
Bo Yuan, Janice Smith, April Ewton, Sai Ravi Pingali, Arthur Zieske, Amy Breman 
Department of Molecular & Human Genetics, Baylor College of Medicine (BY, JS, AB), Houston, 
TX 77030, USA. Baylor Genetics (BY, JS, AB), Houston, TX 77030, USA, by2@bcm.edu; 
breman@bcm.edu. Department of Pathology Genomic Medicine, Houston Methodist Hospital (AE, 
AZ), Houston, TX 77030, USA. Department of Medicine, Houston Methodist Hospital (SRP), 
Houston, TX 77030, USA. 
Published in Atlas Database: November 2017 
Online updated version : http://AtlasGeneticsOncology.org/Reports/t0303p24q26BremanID100091.html 
Printable original version : http://documents.irevues.inist.fr/bitstream/handle/2042/70473/11-2017-t0303p24q26BremanID100091.pdf 
DOI: 10.4267/2042/70473
This work is licensed under a Creative Commons Attribution-Noncommercial-No Derivative Works 2.0 France Licence. 
© 2019 Atlas of Genetics and Cytogenetics in Oncology and Haematology 
Abstract 
Case report on a new case of adult Acute Myeloid 
Leukemia with t(3;3)(p24;q26). 
Clinics 
Age and sex 
68 years old female patient. 
Previous history 
No preleukemia; no previous malignancy; no inborn 
condition of note  
Organomegaly 
No hepatomegaly; splenomegaly (acute 
splenomegaly); no enlarged lymph nodes; no central 
nervous system involvement  
Blood 
WBC: 9.13; RBC: 2.37X 109/l 
HB: 6.7g/dl 





AML with a translocation or inversion in 
chromosome 3; Refractory acute myelogenous 
leukemia with poor risk cytogenetics, pancytopenia 
secondary to refractory AML, acute Splenomegaly, 
fatigue, petechiae, dyspnea on exertion, neutropenic 
fever, refractory thrombocytopenia with hematuria 
and persistence of disease. 
Immunophenotype 
CD34: positive in blasts that account for 45% of 
cellularity; CD61: positive in megakaryocytes. 
MPO: Positive in background myeloid cells. 
Negative in blasts. E-Cadherin and glycophorin: 
Highlights markedly decreased erythroid precursors 
Rearranged Ig Tcr Not performed 
Pathology 
The marrow cellularity is approximately 90% 
(biopsy/clot); Erythroid elements: Markedly 
decreased number. Normoblastic; Myeloid 
elements: Left shifted with increased blasts. Blasts 
account for 18% of cells in the dilute aspirate and 
about 45 of cells in the CD34 immunostained biopsy. 
Eosinophilia is seen on biopsy specimen; 
Megakaryocytes: Markedly increased in number 
with clustering and markedly dyspoietic morphology 
(small hypolobulated, dysjointed nuclei, 
hyperlobed); Reticulin stain shows Grade 1 fibrosis. 
Electron microscopy Not performed 
Diagnosis 
Acute myelogenous leukemia 
Survival 
Date of diagnosis 02-2017 
Treatment 
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Reduced dose of anthracycline therapy due to 
cardiac function; Cytarabine and idarubicin; 
Dacogen; Nivolumab; Decitabine; Hydroxyurea 
Complete remission: no   
Treatment related death: no   
Relapse: no   
Status Alive 
Last follow up 05-2017 
Survival 3 months 
Karyotype 
Sample Bone marrow 
Culture time 24 and 48 hours unstimulated cultures 




Figure 1. Karyotype of the cell line demonstrating the 
t(3;3)(p24;q26) and loss of a copy of chromosome 7 (red 
arrows). The lower panel shows the abnormal 
chromosomes 3 at increasing band resolution. 
Other molecular cytogenetics technics 
Fluorescence in situ Hybridization (FISH) 
Other molecular cytogenetics results 
Confirmatory FISH using the Cytocell EVI1 
Breakapart Probe (REF: LPH 036-A / LPH 036-
A50) was performed on cells harvested from 24 hour 
bone marrow culture. The FISH probe mixture 
consists of a 156 kb probe telomeric to the D3S4415 
marker including the LRRC34 gene (red, R), a 179 
kb probe including the entire EVI1 (MECOM) gene 
plus flanking regions (green, G), and a 559 kb probe 
centromeric to the EVI1 gene including the 
D3S3364 marker (aqua, A), all within the 3q26.2 
region. Interphase cells showed a 1R/1GA/1RGA 
signal pattern, corresponding to one split red/green 
signal with the aqua signal remaining with the green 
signal, confirming the translocation breakpoint 
between the EVI1 and LRRC34 genes (Figure 2). 
However, the partner of EVI1 resulting from the 
translocation remains unknown. 
 
Figure 2. FISH using the Cytocell EVI1 Breakapart Probe 
demonstrating the breakpoint at 3q26.2 between EVI1 and 
LRRC34, a gene telomeric to EVI1, in both interphase (A) 
and metaphase cells (B). 
Comments 
Rearrangements involving the 3q26 region have 
been described in up to 10% of acute myeloid 
leukemias (AML), chronic myeloid leukemias in 
blast crisis (CML BC), and myelodysplastic 
syndrome (Poppe 2006). The most common 
rearrangement is a paracentric inversion of the long 
arm, inv(3)(q21q26), although multiple 
rearrangements of this region have been described 
(Huret 2005, Jancuskova 2014, Lawce 2017). While 
the breakpoints are variable and may include 
translocations, inversions or other structural 
complexities, they unanimously result in EVI1 
overexpression. Interphase FISH assays have been 
used to detect rearrangements involving the EVI1 
locus at 3q26 (Wieser 2003). Monosomy 7 is also 
frequently present, and is associated with a poorer 
prognosis (Haferlach 2012, Huret 2005, Lugthart 
2010). While multiple partners have been identified 
for EVI1, the partner of EVI1 in rearrangements 
involving 3p24 and 3q26 is unknown. Similar to the 
current case, a pericentric inversion involving both 
the short and long arms of chromosome 3, 
inv(3)(p24q26), has been reported in ten cases 
(Haferlach 2012), with elevated EVI1 expression 
reported. Therefore, identification of the partner 
gene warrants further investigation. 
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